Phase 2a Study of the Efficacy and Safety of TRX-100 in a Human Influenza A Challenge Model

Summary

This will be a randomized, double-blind, placebo-controlled proof of concept study to evaluate the prophylactic efficacy and safety of orally administered TRX-100 in healthy adults challenged with influenza A/France/759/2021 (H1N1) virus.

Timeline

Start

2026-06

Primary completion

2026-11

Completion

2027-04

Drugs

Indications